<DOC>
	<DOCNO>NCT02609711</DOCNO>
	<brief_summary>primary object : Evaluate pharmacokinetic drug-drug interaction Candesartan Atorvastatin</brief_summary>
	<brief_title>Investigate Interaction Candesartan Atorvastatin Healthy Male Sugjects</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Adult healthy male 20 45 year screen . BMI 1829 kg/m2 History cardiovascular , respiratory , hepatic , renal , neuropsychiatric , endocrine , hematologic disease Hypersensitivity reactions drug significant hypersensitivity reaction history Candesartan Atorvastatin Hypotension ( DBP ≤ 100 mmHg SBP ≤ 95mmHg ) hypertension ( SBP ≥ 150 mmHg DBP ≥ 95 mmHg ) Gastrointestinal disease affect absorption medication Genetic disease Galactose intolerance , Lapp lactose deficiency glucosegalactose malabsorption AST ALT &gt; 2 x normal range Total bilirubin &gt; 2.0 mg/dl CK &gt; 2 x normal range eGFR &lt; 60 mL/min/1.73m2 Subject drunken habitually ( alcohol 21 units/week , 1 unit = 10 g = 12.5 mL pure alcohol ) unable quit drinking study Subject smoke habitually 10 cigarettes/day unable quit smoking study Subject treat investigational drug within 90 day administration investigational drug Previously donate whole blood within 60 day component blood within 30 day transfusion within 30 day Subject treat drug within 30 day affect absorption , distribution , metabolism , excretion candesartan atorvastatin Subject treat Rx drug herbal drug within 14 day OTC within 7 day History drug abuse Genetic neuromuscular disorder family history neuromuscular disorder Unusual diet affect absorption , distribution , metabolism , excretion medication Subjects deem ineligible investigator base reason</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>